"Histone Deacetylase 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A histone deacetylase subtype that is found along with HISTONE DEACETYLASE 2; RETINOBLASTOMA-BINDING PROTEIN 4; and RETINOBLASTOMA-BINDING PROTEIN 7 as core components of histone deacetylase complexes.
| Descriptor ID |
D056284
|
| MeSH Number(s) |
D08.811.277.087.520.500.100 D08.811.277.087.520.750.100 D08.811.600.620.100 D08.811.600.795.100
|
| Concept/Terms |
Histone Deacetylase 1- Histone Deacetylase 1
- Deacetylase 1, Histone
- HDAC1 Histone Deacetylase
- Deacetylase, HDAC1 Histone
- Histone Deacetylase, HDAC1
- RPD3L1 Histone Deacetylase
- Deacetylase, RPD3L1 Histone
- Histone Deacetylase, RPD3L1
|
Below are MeSH descriptors whose meaning is more general than "Histone Deacetylase 1".
Below are MeSH descriptors whose meaning is more specific than "Histone Deacetylase 1".
This graph shows the total number of publications written about "Histone Deacetylase 1" by people in this website by year, and whether "Histone Deacetylase 1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 5 | 5 |
| 2003 | 0 | 3 | 3 |
| 2005 | 0 | 2 | 2 |
| 2006 | 0 | 3 | 3 |
| 2007 | 0 | 3 | 3 |
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 4 | 4 |
| 2010 | 3 | 2 | 5 |
| 2011 | 1 | 1 | 2 |
| 2012 | 0 | 2 | 2 |
| 2013 | 3 | 3 | 6 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 1 | 2 |
| 2016 | 1 | 1 | 2 |
| 2017 | 2 | 1 | 3 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 1 | 2 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Histone Deacetylase 1" by people in Profiles.
-
USF2 and TFEB compete in regulating lysosomal and autophagy genes. Nat Commun. 2024 Sep 27; 15(1):8334.
-
A CRISPR-Cas9 repressor for epigenetic silencing of KRAS. Pharmacol Res. 2021 02; 164:105304.
-
Role for carbohydrate response element-binding protein (ChREBP) in high glucose-mediated repression of long noncoding RNA Tug1. J Biol Chem. 2020 11 20; 295(47):15840-15852.
-
KRCC1: A potential therapeutic target in ovarian cancer. FASEB J. 2020 02; 34(2):2287-2300.
-
Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma. Blood. 2019 01 24; 133(4):306-318.
-
Covalent Modifications of Histone H3K9 Promote Binding of CHD3. Cell Rep. 2017 Oct 10; 21(2):455-466.
-
HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells. Cancer Res. 2017 09 15; 77(18):5039-5053.
-
HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia. Leukemia. 2018 01; 32(1):49-60.
-
Inhibiting sphingosine kinase 2 mitigates mutant Huntingtin-induced neurodegeneration in neuron models of Huntington disease. Hum Mol Genet. 2017 04 01; 26(7):1305-1317.
-
De Novo Mutations in CHD4, an ATP-Dependent Chromatin Remodeler Gene, Cause an Intellectual Disability Syndrome with Distinctive Dysmorphisms. Am J Hum Genet. 2016 Oct 06; 99(4):934-941.